Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals had revenue of $207.61M in the quarter ending September 30, 2026, with 8.22% growth. This brings the company's total for the last twelve months to $745.79M, up 3.11% year-over-year. In the year 2025, Amphastar Pharmaceuticals had annual revenue of $719.89M, down -1.65%. That makes Amphastar Pharmaceuticals the 9,084th largest company in the world by revenue and 2,019th in the United States.

• Revenue (ttm): $745.79M
• Revenue Growth: +3.11%
• P/S Ratio: 1.63
• Revenue / Employee: $377,423
• Employees: 1,976
• Market Cap: 1.22B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 681.42M 94.7%
• France 35.28M 4.9%
• China 3.18M 0.4%

Fiscal year ended Dec 31, 2025 See the full Amphastar Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	719.89M	-12.08M	-1.65%
Dec 31, 2024	731.97M	87.57M	13.59%
Dec 31, 2023	644.40M	145.41M	29.14%
Dec 31, 2022	498.99M	61.22M	13.98%
Dec 31, 2021	437.77M	87.92M	25.13%
Dec 31, 2020	349.85M	27.49M	8.53%
Dec 31, 2019	322.36M	27.69M	9.40%
Dec 31, 2018	294.67M	54.49M	22.69%
Dec 31, 2017	240.18M	-14.99M	-5.87%
Dec 31, 2016	255.17M	3.65M	1.45%
Dec 31, 2015	251.52M	41.06M	19.51%
Dec 31, 2014	210.46M	-19.22M	-8.37%
Dec 31, 2013	229.68M	25.36M	12.41%
Dec 31, 2012	204.32M	85.97M	72.63%
Dec 31, 2011	118.36M	-12.38M	-9.47%
Dec 31, 2010	130.74M	46.46M	55.13%
Dec 31, 2005	84.28M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error